Skip to main content
. 2013 Oct 14;110(44):17969–17974. doi: 10.1073/pnas.1309362110

Fig. 3.

Fig. 3.

Heterozygosity of p63 prevents ASPP2Δexon3/+ BALB/c mice from developing SCC. (A) Tumor-free survival and (B) tumor incidence and spectrum in ASPP2/p63 compound mice with indicated genotypes over 80 wk [**P = 0.0086 by log-rank (Mantel–Cox) test].